STERNA BIOLOGICALS GMBH & CO KG has a total of 38 patent applications. It increased the IP activity by 250.0%. Its first patent ever was published in 2011. It filed its patents most often in Canada, Brazil and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ROGOSIN INST INC, PHARMADIGM INC and MJ BIOLOG INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 7 | |
#2 | Brazil | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Australia | 4 | |
#6 | United States | 4 | |
#7 | China | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Hungary | 1 | |
#10 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials | |
#6 | Syringes | |
#7 | Sugars | |
#8 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Renz Jonas | 23 |
#2 | Bille Joachim | 13 |
#3 | Runkel Frank | 4 |
#4 | Turowska Agnieszka | 4 |
#5 | Schmidts Thomas | 4 |
#6 | Jonas Renz | 3 |
#7 | Garn Holger | 3 |
#8 | Rupp Thomas | 2 |
#9 | Joachim Bille | 2 |
#10 | Thomas Schmidts | 1 |
Publication | Filing date | Title |
---|---|---|
EP3805242A1 | Method for the production of a catalytically active dna molecule having improved activity and its use in a method of treating asthma | |
EP3603617A1 | Aerosol generating device for inhalatory administration of an antisense molecule containing composition | |
EP3514235A1 | Composition for the treatment of a patient suffering from ulcerative colitis and utilisation of said composition as medicament | |
EP3501607A1 | Composition for the treatment of a patient suffering from a chronic inflammatory airway disease and manufacturing method and use of said composition | |
HUE046190T2 | Gata-3 inhibitors for use in the treatment of th2-driven asthma |